| MEDI | Wednesday, August 22, 2007 | ||
8:30 AM-11:50 AM BCEC -- 210A, Oral | |||
New Approaches for the Treatment of Pulmonary Inflammatory Diseases | |||
| Organizer: | Steve Tam | ||
| 8:30 AM | 246 | The pathobiology of asthma and COPD: Targeting new pathways for treatment William M. Abraham | |
| 9:10 AM | 247 | Protease inhibitors for treating pulmonary inflammatory disorders: Focus on chymase and cathepsin G Bruce E. Maryanoff, M. N. Greco, M. J. Hawkins, E. T. Powell, L. De Garavilla, H. R. Almond Jr. | |
| 9:50 AM | 248 | Discovery of AMG 009: A CRTH2 and DP dual-antagonist Julio C. Medina, Jiwen Liu, Zice Fu, Michael Schmitt, Yingcai Wang, Marshall C. Derek, H. Lucy Tang, Timothy Sullivan, George Tonn, Tassie Collins | |
| 10:30 AM | 249 | Structure activity relationships of a series of thiazolopyrimidine based CXCR2 antagonists with additional CCR2b activity Iain A. S. Walters | |
| 11:10 AM | 250 | Discovery of R411: A VCAM/VLA-4 antagonist for the treatment of asthma Jefferson W. Tilley, Achyutharao Sidduri, Li Chen, Jiang Ping Lou, Gerald Kaplan, Gary Cavallo, Nadine Tare, Lou Renzetti, Horst Welker, Alexis Rames | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 234th ACS National Meeting, Boston, MA, August 19-23, 2007